Jana Peters
Family Medicine · Princeton, WVNPI 1952444234
Payments from drug & device makers
Across 119 payments — averaging $15.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$422
- Amgen$160
- Novo Nordisk$151
- Merck$133
- AbbVie$115
- Ferring Pharmaceuticals Inc.$94
- plus $716 from 18 others
What the payments were for
- Food & beverage$1,791100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 30 | $422 |
| Amgen(2 entities) | 10 | $160 |
| Novo Nordisk | 10 | $151 |
| Merck | 15 | $133 |
| AbbVie(2 entities) | 7 | $115 |
| Ferring Pharmaceuticals Inc. | 5 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $83 |
| Pfizer | 4 | $63 |
| Exact Sciences | 3 | $63 |
| Abbott | 3 | $62 |
| Novartis | 3 | $47 |
| Dexcom, Inc. | 3 | $47 |
| Eisai Inc. | 2 | $40 |
| GSK | 2 | $40 |
| Hologic Sales And Service, LLC | 2 | $39 |
| Johnson & Johnson | 2 | $34 |
| Bayer | 2 | $33 |
| Optinose US, Inc. | 2 | $31 |
| Genentech USA, Inc. | 2 | $29 |
| Alkermes, Inc. | 1 | $26 |
| AstraZeneca | 2 | $24 |
| Idorsia Pharmaceuticals US Inc | 1 | $21 |
| La Jolla Pharmaceutical Company | 1 | $20 |
| Boehringer Ingelheim | 1 | $15 |
How this compares
$1,791 in reported general payments places this provider in the 75th percentile of 843 family medicine providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 43 | $40,949 |
| OzempicSemaglutide | 16 | $20,863 |
| XareltoRivaroxaban | 16 | $14,912 |
| TrulicityDulaglutide | 12 | $11,538 |
| TradjentaLinagliptin | 15 | $10,052 |
| JanuviaSitagliptin Phosphate | 15 | $9,374 |
| Gabapentin | 321 | $3,827 |
| Pregabalin | 88 | $1,463 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 56 | $1,185 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 49 | $1,165 |
| Levothyroxine Sodium | 141 | $1,069 |
| SynthroidLevothyroxine Sodium | 13 | $962 |
| Temazepam | 27 | $889 |
| Losartan Potassium | 72 | $757 |
| Atorvastatin Calcium | 95 | $722 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $63 | $40,94943 claims |
| Novo NordiskOzempic | $151 | $20,86316 claims |
| Johnson & JohnsonXarelto | $34 | $14,91216 claims |
| Lilly USA, LLCTrulicity | $422 | $11,53812 claims |
| Boehringer IngelheimTradjenta | $15 | $10,05215 claims |
| MerckJanuvia | $133 | $9,37415 claims |
| AbbVieSynthroid | $115 | $96213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 843 family medicine providers in West Virginia.
Other family medicine in Princeton
- Ryan RunyonPrinceton$21K
- Phillip PetersonPrinceton$7K
- Wilbur SineMorgantown$179K
- Dorian WilliamsMorgantown$169K
- Julie DetempleSouth Charleston$129K
- Clemente DiazRichwood$127K
- John CornellHuntington$94K
- Mark CucuzzellaHarpers Ferry$59K
- Courtney PilkertonMorgantown$45K
- Isha WoofterClarksburg$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.